Synergistic Antioxidant and Anti-Ferroptosis Therapy via BPNS-Encapsulated Thermoresponsive Chitosan Hydrogel for Spinal Cord Injury Regeneration
Pharmaceutics · 26.04.2025 · 17 (5) · 573
DOI: 10.3390/pharmaceutics17050573 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 26.04.2025. Verfasst von Yang Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Guangxi University, Nanning 530004, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Joint Funds for the innovation of science and Technology, Fujian province.
Abstract (Originalsprache)
Background
Spinal cord injury (SCI) is a devastating neurological condition with limited therapeutic options. Current clinical interventions predominantly rely on prolonged or high-dose pharmacological regimens, often causing systemic toxicity and adverse events. Although black phosphorus nanosheets (BPNSs) exhibit remarkable reactive oxygen species (ROS)-scavenging capacity to mitigate oxidative damage, their rapid degradation severely compromises their therapeutic efficacy.
Methods
This study presents a thermosensitive hydrogel with rapid gelation properties by incorporating different proportions and concentrations of sodium alginate (SA) into a chitosan/β-glycerophosphate (CS/β-GP) hydrogel and loading it with BPNS for the treatment of SCI in rats. In vitro, the physical properties of the composite were characterized and the cytotoxicity and ROS scavenging abilities were assessed using PC12 cells; in vivo, behavioral tests, histopathological analysis, transcriptomics, immunohistochemistry, and Western blotting were performed to explore the therapeutic effects and mechanisms.
Results
The results demonstrate that this hydrogel effectively slows BPNS degradation, exhibits a high ROS scavenging capacity, reduces lipid peroxidation, and thereby inhibits ferroptosis and apoptosis, offering neuroprotective effects and promoting motor function recovery.
Conclusions
Our findings establish the CS/β-GP/SA-BPNS hydrogel as a multifunctional therapeutic platform for SCI, synergizing sustained drug release with ROS–ferroptosis–apoptosis axis modulation to achieve neuroprotection and functional restoration. This strategy provides a translatable paradigm for combining nanotechnology and biomaterial engineering in neural repair.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Guangxi University, Nanning 530004, China.
- Fujian Maternity and Child Health Hospital, Fuzhou 350001, China.
- Fujian Provincial Human Sperm Bank, Fuzhou 350001, China.
- College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou 350122, China.
- Stem Cell Therapy Research Center, Fuzhou 350001, China.
Förderung
- Joint Funds for the innovation of science and Technology, Fujian province
Zitieren
APA
Liu, Y., Wang, Y., Wang, X., Zeng, W., Zhang, Z., Zhang, Z., & Qi, Z. (2025). Synergistic Antioxidant and Anti-Ferroptosis Therapy via BPNS-Encapsulated Thermoresponsive Chitosan Hydrogel for Spinal Cord Injury Regeneration. Pharmaceutics, 17(5), 573. https://doi.org/10.3390/pharmaceutics17050573
Vancouver
Liu Y, Wang Y, Wang X, Zeng W, Zhang Z, Zhang Z, et al. Synergistic Antioxidant and Anti-Ferroptosis Therapy via BPNS-Encapsulated Thermoresponsive Chitosan Hydrogel for Spinal Cord Injury Regeneration. Pharmaceutics. 2025;17(5):573. doi:10.3390/pharmaceutics17050573
BibTeX
@article{Liu2025,
author = {Liu, Yang and Wang, Yingkai and Wang, Xiangzi and Zeng, Wanchen and Zhang, Zehong and Zhang, Zhengmian and Qi, Zhongquan},
title = {Synergistic Antioxidant and Anti-Ferroptosis Therapy via BPNS-Encapsulated Thermoresponsive Chitosan Hydrogel for Spinal Cord Injury Regeneration},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {5},
pages = {573},
doi = {10.3390/pharmaceutics17050573}
}
EUVIMED